Connecticut Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$748K Sell
2,670
-74
-3% -$19.5K 0.03% 198
2026
Q1
$732K Hold
2,744
– – 0.03% 190
2025
Q4
$688K Hold
2,744
– – 0.03% 193
2025
Q3
$788K Hold
2,744
– – 0.04% 176
2025
Q2
$720K Hold
2,744
– – 0.03% 184
2025
Q1
$639K Sell
2,744
-135
-5% -$32.8K 0.03% 190
2024
Q4
$660K Buy
2,879
+84
+3% +$19.3K 0.03% 165
2024
Q3
$625K Sell
2,795
-27
-1% -$5.93K 0.03% 197
2024
Q2
$574K Sell
2,822
-151
-5% -$30.7K 0.03% 204
2024
Q1
$649K Buy
2,973
+52
+2% +$11.5K 0.03% 190
2023
Q4
$664K Buy
+2,921
New +$614K 0.04% 185

Other funds holding LH

Connecticut Wealth Management's LH Position: Q2 2026 in Review

Connecticut Wealth Management reduced its Labcorp (LH) stake by 2.7% in Q2 2026, selling an estimated $19.5K and leaving 2,670 shares worth $748K. The position accounts for 0.03% of the portfolio, ranked #198.

Connecticut Wealth Management first reported a position in LH in Q4 2023 and has held it in 11 quarters since. The position peaked at $788K in Q3 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Connecticut Wealth Management held 2,670 shares of Labcorp worth $748K as of Q2 2026.
  • Connecticut Wealth Management sold 74 Labcorp shares in Q2 2026, an estimated $19.5K.
  • Labcorp made up 0.03% of Connecticut Wealth Management's portfolio in Q2 2026, its #198 holding.
  • Connecticut Wealth Management first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
  • Connecticut Wealth Management's Labcorp position peaked at $788K in Q3 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Connecticut Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.